Key result
Coronary calcium scanning is discussed as a potential noninvasive screening tool for subclinical atherosclerosis in asymptomatic patients with diabetes.
Why the study?
Do asymptomatic or mildly symptomatic people with diabetes benefit from coronary calcium scans?
Do asymptomatic or mildly symptomatic people with diabetes benefit from coronary calcium scans?
Answers are grounded in this paper and cite their sources.
This editorial discusses the rationale and debate surrounding the use of coronary calcium screening for subclinical atherosclerosis in patients with diabetes.
Admission of ignorance is the first step toward knowledge . —Benjamin Disraeli Cardiovascular disease is responsible for most death and disability associated with diabetes. Those with diabetes suffer two to four times more myocardial infarctions, strokes, and sudden deaths than those without this condition (1–3). The medical community has recognized the increased vulnerability of these patients by assigning diabetes “coronary heart disease equivalent” status in its prevention guidelines (4). Since coronary syndromes tend to be clinically atypical and difficult to diagnose in diabetes, noninvasive approaches in asymptomatic or mildly symptomatic subjects have been proposed for screening and diagnosis (5,6). Pathologic studies have demonstrated a strong correlation between the presence of coronary calcium and the amount of atheromatous plaque (7). Since sensitive and noninvasive radiographic techniques are capable of detecting and quantitating calcium, calcium screening is an obvious candidate for screening for subclinical atherosclerosis. Morrison (8) has defined the purpose of screening for chronic diseases. “Screening for disease control can be defined as the examination of asymptomatic people in order to classify them as likely or not likely to have the disease that is the object of screening […]. The goal of screening is to reduce morbidity and mortality from disease among the people screened by early treatment of the cases discovered.” If one accepts this definition, one can then surmise that three distinct …
No takes yet. Share an insight, caveat, or question.
Robert Detrano (2003) conducted an editorial in Diabetes. Coronary calcium scans was evaluated. Coronary calcium scanning is discussed as a potential noninvasive screening tool for subclinical atherosclerosis in asymptomatic patients with diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: